C&EN, February 12, 2018
Directive on Good Manufacturing Practices could help level the competitive playing field.
Europe has long been the center of global active pharmaceutical ingredient (API) production, but producers in India and China are rapidly eroding the region's leading position. When it comes to making generic APIs, the volume from India and China together already outstrips that from Europe. Along with this stiff competition, European producers face overcapacity problems at home and a crowded, undifferentiated marketplace.